Basic patent to nanoparticle drug delivery issued to NanoDel
July 25, 2008 – 5:05 pmNanoDel is a German company involved in the development of nanoparticles for drug delivery across the blood-brain barrier. Researchers from NanoDel have contributed to the scientific investigation of nanoparticles for drug delivery for over a decade and have just recently received a fairly basic patent to the use of polyalkylcyanoacrylate nanoparticles for administering DNA.
You must be logged in to post a comment.